Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high. Vertex has certainly been impressive, but are the company's best days already in the rearview mirror?